多中心前瞻性随机研究:结肠胶囊内镜与CT结肠成像在筛查人群中诊断产出的比较(TOPAZ研究)
TOPAZ研究将50-75岁平均风险筛查人群随机分配至结肠胶囊内镜(CCE)或CT结肠成像(CTC),后续盲法光学结肠镜(OC)验证。CCE对≥6mm息肉的诊断产出优于CTC,对≥10mm息肉非劣于CTC,两者均安全耐受,但均不及OC。
要点
- CCE对≥6mm息肉的诊断产出为31.6%,显著优于CTC的8.6%。
- CCE对≥6mm息肉灵敏度79.2%、特异度96.3%,CTC为26.8%和98.9%。
- CCE对≥10mm息肉诊断产出13.5%,非劣于CTC的6.3%。
核心结论
- CCE对≥6mm息肉的诊断产出优于CTC,对≥10mm息肉非劣于CTC。
- CCE可作为与CTC相当或更优的结直肠肿瘤筛查试验,但两者均不如OC有效。
研究设计与样本
- 多中心、前瞻性、随机研究,50-75岁(非裔美国人45-75岁)平均风险筛查人群随机接受CCE或CTC,随后盲法OC。
- 共入组320例,286例(89.4%)数据可评估。
主要发现
- OC确认≥6mm息肉的比例:CCE组31.6% vs CTC组8.6%(非劣效和优效pPr=0.999)。
- ≥10mm息肉诊断产出:CCE组13.5% vs CTC组6.3%(非劣效pPr=0.9954)。
- CCE对≥6mm息肉灵敏度79.2%、特异度96.3%;CTC灵敏度26.8%、特异度98.9%。
- CCE对≥10mm息肉灵敏度85.7%、特异度98.2%;CTC灵敏度50%、特异度99.1%。
- 两种检查均耐受良好且安全。
关键数值与推荐
- 主要终点为CCE或CTC对≥6mm息肉的诊断产出。
- 次要终点包括大小和组织学准确性、检查完整性、≥6mm和≥10mm息肉/腺瘤受试者数量/比例、受试者满意度和安全性。
临床怎么用
- 在平均风险筛查人群中,CCE对≥6mm息肉的检出优于CTC,可考虑作为CTC的替代或更优选择。
- CCE和CTC均不能替代OC,临床选择需结合筛查目标和资源。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Colon capsule endoscopy (CCE) has shown promise for colorectal neoplasia detection compared with optical colonoscopy (OC), but has not been compared with other screening tests in average risk screening patients. DESIGN: Patients 50 to 75 years of age (African Americans, 45-75 years) were randomised to CCE or CT colonography (CTC) and subsequent blinded OC. The primary endpoint was diagnostic yield of polyps ≥6 mm with CCE or CTC. Secondary endpoints included accuracy for size and histology, examination completeness, number/proportion of subjects with polyps and adenomas ≥6 mm and ≥10 mm, subject satisfaction and safety. RESULTS: From 320 enrolled subjects, data from 286 (89.4%) were evaluable. The proportion of subjects with any polyp ≥6 mm confirmed by OC was 31.6% for CCE versus 8.6% for CTC (pPr non-inferiority and superiority=0.999). The diagnostic yield of polyps ≥10 mm was 13.5% with CCE versus 6.3% with CTC (pPr non-inferiority=0.9954). The sensitivity and specificity of CCE for polyps ≥6 mm was 79.2% and 96.3% while that of CTC was 26.8% and 98.9%. The sensitivity and specificity of CCE for polyps ≥10 mm was 85.7% and 98.2% compared with 50% and 99.1% for CTC. Both tests were well tolerated/safe. CONCLUSION: CCE was superior to CTC for detection of polyps ≥6 mm and non-inferior for identification of polyps ≥10 mm. CCE should be considered comparable or superior to CTC as a colorectal neoplasia screening test, although neither test is as effective as OC. TRIAL REGISTRATION NUMBER: ClinicalTrials.gov no: NCT02754661.
引用
- Cash BD, Fleisher MR, Fern S, et al. Multicentre, prospective, randomised study comparing the diagnostic yield of colon capsule endoscopy versus CT colonography in a screening population (the TOPAZ study). Gut. 2020. PMID: 33443017. doi:10.1136/gutjnl-2020-322578
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。